Phenotypic and genotypic characterization of food animal isolates of Salmonella with reduced sensitivity to ciprofloxacin

Microbial Drug Resistance

Volumn 8, Issue 4, 2002, Pages 375-383

  Allen, Kevin J ^a   Poppe, Cornelius ^a  

^a HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CARBADOX; CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; GENTAMICIN; KANAMYCIN; NALIDIXIC ACID; NEOMYCIN; PROTEIN; PROTEIN PARC; RESERPINE; SPECTINOMYCIN; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA SEQUENCE; GENOTYPE; MINIMUM INHIBITORY CONCENTRATION; MUTATION RATE; NONHUMAN; OPERON; PHENOTYPE; PLASMID; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SALMONELLA; SEROTYPE; SINGLE STRAND CONFORMATION POLYMORPHISM;

ANIMALIA; BACTERIA (MICROORGANISMS); GALLUS GALLUS; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA; SALMONELLA TYPHIMURIUM;

EID: 0036929530     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/10766290260469651     Document Type: Article

References (31)

1. Axon, J.M.C., and E.C. Huskisson. 1992. Use of aspirin in inflammatory diseases. In J.R. Vane and R.M. Botting (ed.), Aspirin and Other Salicylates. Chapman & Hall, London, England, pp. 295-320.
2. Breines, D.M., S. Ouabdesselam, E.Y. Ng, J. Tankovic, S. Shah, C.J. Soussy, and D.C. Hooper. 1997. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV. Antimicrob. Agents Chemother. 41:175-179.
3. Brown, J.C., C.J. Thomson, and S.G. Amyes. 1996. Mutations of the gyrA gene of clinical isolates of Salmonella typhimurium and three other Salmonella species leading to decrease susceptibilities to 4-quinolone drugs. J. Antimicrob. Chemother. 37:351-356.
4. Centers for Disease Control and Prevention. 1998. Standardized Molecular Subtyping of Foodborne Bacterial Pathogens by Pulsed-field Gel Electrophoresis. CDC, Atlanta, Georgia.
5. Crosa, J.H., and S. Falkow. 1981. Plasmids. In P. Gerhardt (ed.), Manual of Methods for General Bacteriology. American Society for Microbiology, Washington, D.C., pp. 267-268.
6. Deguchi, T., A. Fukuoka, M. Yasuda, M. Nakano, S. Ozeki, E. Kanematsu, Y. Nishino, S. Ishihara, Y. Ban, and Y. Kawada. 1997. Alterations in GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob. Agents Chemother. 41:699-701.
7. Everett, M.J., Y.F. Jin, V. Rici, and L.J.V. Piddock. 1996. Contribution of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals. Antimicrob. Agents Chemother. 40:2380-2386.
8. Giraud, E., A. Brisabois, J-L. Martel, and E. Chaslus-Dancla. 1999. Comparative studies of mutations in animal isolates and experimental in vitro and in vivo-selected mutants of Salmonella spp. suggest a counterselection of highly fluoroquinolone-resistant strains in the field. Antimicrob. Agents Chemother. 43:2131-2137.
9. Giraud, E., A. Cloeckaert, D. Kerboeuf, and E. Chaslus-Dancla. 2000. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar Typhimurium. Antimicrob. Agents Chemother. 44:1223-1228.
10. Griggs, D.J., K. Gensberg, and L.J.V. Piddock. 1996. Mutations in gyrA gene of quinolone-resistant Salmonella serotypes isolated from humans and animals. Antimicrob. Agents Chemother. 40:1009-1013.
11. Gustafson, J.E., P.V. Candelaria, S.A. Fisher, J.P. Goodridge, T.M. Lichocik, T.M. McWilliams, C.T.D. Price, F.G. O'Brien, and W.B. Grubb. 1999. Growth in the presence of salicylate increases fiuoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 43:990-992.
12. Heisig, P. 1996. Genetic evidence for a role of parC mutations in development of high level fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 40:879-885.
13. Heisig, P., B. Kratz, E. Halle, Y. Graser, M. Altwegg, W. Rabsch, and J.P. Faber. 1995. Identification of DNA gyrase A mutations in ciprofloxacin-resistant isolates of Salmonella typhimurium from men and cattle in Germany. Microb. Drug Resist. 1:211-218.
14. Heurtin-Le Corre, C., P-Y. Connio, M. Perrin, M-F. Travert, and J-L. Avril. 1999. Increasing incidence and comparison of nalidixic acid-resistant Salmonella enterica subsp. enterica serotype Typhimurium isolates from humans and animals. J. Clin. Microbiol. 37:266-269.
15. Hooper, D.C. 2000. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. 31(Suppl. 2):S24-28.
16. Khodursky, A.B., E.L. Zechiedrich, and N.L. Cozzarelli. 1995. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc. Natl. Acad. Sci. USA 92:11801-11805.
17. LeClerc, J.E., L. Baoguang, W.L. Payne, and T.A. Cebula. 1996. High mutation frequencies among Escherichia coli and Salmonella pathogens. Proc. Natl. Acad. Sci. USA 274:1208-1211.
18. Mead, P.S., L. Slutsker, V. Dietz, L.F. McCaig, J.S. Bressee, C. Shapiro, P.M. Griffin, and R.V. Tauxe. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis. 5:607-625.
19. National Committee for Clinical Laboratory Standards. 1999. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals: Approved Standard. NCCLS Document M31-A. NCCLS, Villanova, PA.
20. Ouabdesselam, S., J. Tankovic, and C.J. Soussy. 1996. Quinolone resistance mutations in the gyrA gene of clinical isolates of Salmonella. Microb. Drug Resist. 2:299-302.
21. Piddock, L.J.V., V. Ricci, I. McLaren, and D.J. Griggs. 1998. Role of mutation in the gyrA and parC genes of nalidixic-acid-resistant salmonella serotypes isolated from animals in the United Kingdom. J. Antimicrob. Chemother. 41:635-641.
22. Randall, L.P., and M.J. Woodward. 2001. Multiple antibiotic resistance (mar) locus in Salmonella enterica serovar Typhimurium DT104. Appl. Environ. Microbiol. 67:1190-1197.
23. Renya, F., M. Huesca, V. Gonzalez, and L.Y. Fuchs. 1995. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother. 39:1621-1623.
24. Ridley, A., and E.J. Threlfall. 1998. Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella typhimurium DT 104. Microb. Drug Resist. 4:113-118.
25. Ruiz J., D. Castro, P. Goni, J.A. Santamaria, J.J. Borrego, and J. Vila. 1997. Analysis of the mechanism of quinolone resistance in nalidixic acid-resistant clinical isolates of Salmonella serotype Typhimurium. J. Med. Microbiol. 46:623-628.
26. Threlfall, E.J., L.R. Ward, J.A. Frost, and G.A. Willshaw. 2000. Spread of resistance from food animals to man-the UK experience. Emerg. Infect. Dis. 5:189-194.
27. Vila, J., J. Ruiz, P. Goni, and M.T. de Anta. 1996. Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichi coli. Antimicrob. Agents Chemother. 40:490-493.
28. Walker, R.A., A.J. Lawson, E.A. Lindsay, L.R. Ward, P.A. Wright, F.J. Bolton, D.R.A. Wareing, J.D. Corkish, R.H. Davies, and E.J. Threlfall. 2000. Decreased susceptibility to ciprofloxacin in outbreak-associated multiresistant Salmonella typhimurium DT104. Vet. Rec. 147:395-396.
29. Walker, R.A., N. Saunders, A.J. Lawson, E.A. Lindsay, M. Dassama, L.R. Ward, M.J. Woodward, R.H. Davies, E. Liebana, and E.J. Threlfall. 2001. Use of a lightcyler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype Typhimurium DT104 isolates. J. Clin. Microbiol. 39:1443-1448.
30. Wiuff, C., M. Madsen, D.L. Baggesen, and F.M. Aarestrup. 2000. Quinolone resistance among Salmonella enterica from cattle, broilers, and swine in Denmark. Microb. Drug Resist. 6:11-17.
31. Yoshida, H., M. Bogaki, M. Nakamura, L.M. Yamanaka, and S. Nakamura. 1991. Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob. Agents Chemother. 35:1647-1650.